×ÛºÏÎÄ¿âÍø - רҵÎÄÕ·¶ÀýÎĵµ×ÊÁÏ·ÖÏíƽ̨
ËÑ Ë÷
·ÖÀർº½
·¶ÎÄ´óÈ«
·¶ÎÄ
¹¤×÷×ܽá
¹¤×÷¼Æ»®
¹¤×÷±¨¸æ
ÐĵÃÌå»á
ÂÛÎÄ´óÈ«
ÃûÑÔ¾ä×Ó
ÎÄÃØ×ÊÁÏ
¹«ÎÄ×ÊÁÏ
¸å¼þ´óÈ«
ÆÀÓï´óÈ«
×£¸£Óï´óÈ«
¹Ûºó¸Ð´óÈ«
¶Áºó¸Ð´óÈ«
½ÚÈÕÇìµä´óÈ«
ÈëÍÅÈëµ³ÉêÇëÊé
¾µä·¶ÎÄ´óÈ«
ÃÀÎľ«Ñ¡
ÃÀÎÄ
¾µäÃÀÎÄ
Çé¸ÐÃÀÎÄ
°®ÇéÃÀÎÄ
ÕÜÀíÃÀÎÄ
ÓÅÃÀ¾ä×Ó
É¢ÎÄÊ«¸è
΢С˵
Ç©Ãû˵˵
¾µäÓï¼
Óï¾äÕª³
ÀøÖ¾¹ÊÊÂ
ÈÕ¼ÇËæ±Ê
×÷ÎÄ¿¯Àý
×÷ÎÄ
СѧÉú×÷ÎÄ
³õÖÐ×÷ÎÄ
¸ßÖÐ×÷ÎÄ
¿¼ÊÔ×÷ÎÄ
ÎÄ¿â´óÈ«
ÎÄ¿â
Ó׶ù½ÌÓý
Сѧ½ÌÓý
³õÖнÌÓý
½ÌѧÑо¿
רҵ×ÊÁÏ
×ʸñ¿¼ÊÔ
½ÌÓýÎÄ¿â
ÍâÓÊÔ
ÇóÖ°Ö°³¡
¸ßµÈ½ÌÓý
¸ßÖнÌÓý
ʵÓÃÎĵµ
Ê×Ò³
·¶ÎÄ
ÃÀÎÄ
×÷ÎÄ
ÎÄ¿â
×ܽá
¼Æ»®
ÃûÑÔ
¹Ûºó¸Ð
¶Áºó¸Ð
ÉêÇëÊé
ʵÓÃÎĵµ
ÄúµÄµ±Ç°Î»Öãº
Ö÷Ò³
>
ÎÄ¿â
̩ɽҽѧԺ2016ÄêÆÕͨ¸ßµÈ½ÌÓý µÚ3Ò³
1
2
3
4
5
×ÛºÏÎÄ¿â
Ó׶ù½ÌÓý
¸ßÖнÌÓý
Сѧ½ÌÓý
³õÖнÌÓý
¸ßµÈ½ÌÓý
ÍâÓïѧϰ
×ʸñ¿¼ÊÔÈÏÖ¤
½ÌѧÑо¿
ÈËÎÄÉç¿Æ
¾¹ÜÓªÏú
¹¤³Ì¿Æ¼¼
IT¼ÆËã»ú
×ÔÈ»¿Æѧ
Ò½Ò©ÎÀÉú
Å©ÁÖÄÁÓæ
×ÛºÏÎÄ¿â
ÈÈÃűêÇ©
¸·ÑôÊÐ
񻂗
WO
Ñо¿
±ê×¼
½¨¼Ò
MSDC1.1
ÍõÅÆ
¼ªÁÖÊ¡
Îĵµ
¼¼ÊõÓ¦ÓÃ
¼¼ÇÉ
×ù̸
entagac
κÊéÉú
һģ
¼¸ÕÉ
´ðÌâ
ÏÂÔØ
½ÌÓý¾Ö
ʵÓÃ
ÎÒϲ»¶
ʵ¼ù
Éϲá
½¨Òé
³õ¶¨
³õÖÐÕþÖÎ
04¿Î
¹ö¶¯
ÃÅ
×îÐÂ×ÊѶ
¾«ÃÀµÄ¸öÈ˼òÀúÄ£°åÏÂÔØ
µÚ29´ÎÖйú»¥ÁªÍøÂç·¢Õ¹×´¿öͳ¼Æ±¨¸æ - ͼÎÄ
´«¸ÐÆ÷ÔÀíÓëÓ¦ÓÃ×÷Òµ²Î¿¼´ð°¸
2012ÄêÈ«¹ú´óѧÉúÓ¢ÓᄎÈüCÀàÊÔÌâ´ð°¸.
ÎÒ¹ú¹«ÃñµÄ»ù±¾ÒåÎñ½Ì°¸
Biochemical pathways in the antiatherosc
¶à¶÷²¼Ê²¡¶ºê¹Û¾¼Ãѧ¡·¸¨µ¼ÏµÁÐ-¸¨µ¼½²Òå-µÚ4Õ Ôö³¤ÓëÕþ²ß¡¾Ê¥²Å³öÆ·¡¿
ÉúÎﻯѧ¿¼²©¸÷УÀúÄêÕæÌâ(1999-2008)
2020°æ¸ß¿¼ÎïÀíÒ»ÂÖ¸´Ï°¿Îʱ¸ú×Ù¼ì²âÒ»ÃèÊöÔ˶¯µÄ»ù±¾¸ÅÄ½âÎö - ͼÎÄ
»ã¼¯28ÖÖ³£¼û»¨»ÜÑøÖ³·½·¨£¨Åäͼ£©
ÈÈÃÅÅÅÐÐ
ˆæÌ}Ñä?ÊÒÄÚ»·¾³ÖеÄÖ÷Ìâ¡°ÔªËØ¡±Éè¼Æ
ˆæÌ}Ñä?ҽѧӢÓïunit-5×ܽá
°²»ÕÊ¡ÍîÄÏ°ËУ2020½ì¸ßÈýµÚÈý´ÎÁª¿¼»¯Ñ§
ˆæÌ}Ñä?ˆæÌ}Ñä?ˆæÌ}Ñä?×îÐÂÎ÷»ª´óѧרÉý±¾¼ÆËã
»õ±Òʱ¼ä¼ÛÖµµÄ¸ÅÄî¼°ÒâÒ徫±àWORD°æ
ˆæÌ}Ñä?ÊÖ×ã¿Ú²¡·ÀÖÎ֪ʶ½²×ùppt
Copyright © 2012-2022 ×ÛºÏÎÄ¿âÍø °æȨËùÓÐ
ÃâÔðÉùÃ÷
|
ÁªÏµÎÒÃÇ
ÉùÃ÷ :±¾ÍøÕ¾×ðÖز¢±£»¤ÖªÊ¶²úȨ£¬¸ù¾Ý¡¶ÐÅÏ¢ÍøÂç´«²¥È¨±£»¤ÌõÀý¡·£¬Èç¹ûÎÒÃÇתÔصÄ×÷Æ·ÇÖ·¸ÁËÄúµÄȨÀû,ÇëÔÚÒ»¸öÔÂÄÚ֪ͨÎÒÃÇ£¬ÎÒÃǻἰʱɾ³ý¡£
¿Í·þQQ£º370150219 ÓÊÏ䣺370150219@qq.com
ËÕICP±¸16052595ºÅ-7
Top